Arsanis, Inc. | Registration Rights Agreements | Business Contracts

Registration Rights Agreement, dated June 30, 2022, by and among X4 Pharmaceuticals Inc. and the persons party thereto (Filed With SEC on July 1, 2022)

Registration Rights Agreement, dated March 3, 2022, by and among X4 Pharmaceuticals, Inc. and the persons party thereto (Filed With SEC on March 3, 2022)

Registration Rights Agreement, dated as of January 14, 2022, by and between X4 Pharmaceuticals, Inc. and Lincoln Park Capital Fund, LLC (Filed With SEC on January 14, 2022)

Registration Rights Agreement, dated November 5, 2021, by and among X4 Pharmaceuticals, Inc. and the persons party thereto (Filed With SEC on November 5, 2021)

Registration Rights Agreement, dated March 18, 2021, by and among X4 Pharmaceuticals, Inc. and the persons party thereto (Filed With SEC on March 19, 2021)

Registration Rights Agreement, dated October 14, 2020, by and between X4 Pharmaceuticals, Inc. and Aspire Capital Fund, LLC (Filed With SEC on October 16, 2020)

Arsanis, Inc. (102) | Registration Rights Agreements (6)